{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MAPK signaling pathway", "Polygonum orientale L.", "myocardial ischemia"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37175097", "DateCompleted": {"Year": "2023", "Month": "05", "Day": "15"}, "DateRevised": {"Year": "2023", "Month": "05", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "04", "Day": "24"}], "Language": ["eng"], "ELocationID": ["3687", "10.3390/molecules28093687"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "9", "PubDate": {"Year": "2023", "Month": "Apr", "Day": "24"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "<i>Polygonum orientale</i> L. Alleviates Myocardial Ischemia-Induced Injury via Activation of MAPK/ERK Signaling Pathway.", "Abstract": {"AbstractText": ["Although <i>Polygonum orientale</i> L. (PO) has a beneficial effect on treatment of myocardial ischemia (MI), its mechanism remains unclear. This study aimed to explore the pharmacological mechanism of PO against MI through MAPK signaling pathways. Firstly, the therapeutic effect of PO was evaluated for treatment of MI mice. Using Western blot and immunohistochemistry, the influence of PO on MAPK signaling pathways and cell apoptosis was investigated. Subsequently, one key pathway (ERK) of MAPK signaling pathways was screened out, on which PO posed the most obvious impact. Finally, an inhibitor of ERK1/2 was utilized to further verify the regulatory effect of PO on the MAPK/ERK signaling pathway. It was found that PO could reduce the elevation of the ST segment; injury of heart tissue; the activity of LDH, CK, NOS, cNOS and iNOS and the levels of NO, BNP, TNF-\u03b1 and IL-6. It is notable that PO could significantly modulate the protein content of p-ERK/ERK in mice suffering from MI but hardly had an effect on p-JNK/JNK and p-p38/p38. Additionally, the expressions of bax, caspase3 and caspase9 were inhibited in heart tissue in the PO-treated group. To evaluate whether ERK1/2 inhibitor (PD98059) could block the effect of PO on treatment of MI, both PO and PD98059 were given to mice with MI. It was discovered that the inhibitor indeed could significantly reverse the regulatory effects of PO on the above indicators, indicating that PO could regulate p-ERK/ERK. This study provides experimental evidence that PO extenuates MI injury, cardiomyocyte apoptosis and inflammation by activating the MAPK/ERK signaling pathway."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Fu", "ForeName": "Changli", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Wang", "ForeName": "Mingjin", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Lu", "ForeName": "Yuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Pan", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Li", "ForeName": "Yueting", "Initials": "Y"}, {"Identifier": ["0000-0002-0479-6259"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Wang", "ForeName": "Yonglin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Wang", "ForeName": "Aimin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Huang", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Sun", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Liu", "ForeName": "Chunhua", "Initials": "C"}], "GrantList": [{"GrantID": "81803700", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "82260779", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "U1812403", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "[2020]1Z068", "Agency": "Guizhou Provincial Natural Science Foundation", "Country": ""}, {"GrantID": "[2019]1439", "Agency": "Guizhou Provincial Natural Science Foundation", "Country": ""}, {"GrantID": "[2018] 4006", "Agency": "Central Guided Local Science and Technology Special Project", "Country": ""}, {"GrantID": "GCC [2022]031-1", "Agency": "Guizhou Science and Technology Department", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "p38 Mitogen-Activated Protein Kinases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "MAP Kinase Signaling System"}, {"QualifierName": ["metabolism"], "DescriptorName": "Polygonum"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Myocardial Ischemia"}, {"QualifierName": [], "DescriptorName": "Heart"}, {"QualifierName": [], "DescriptorName": "Coronary Artery Disease"}, {"QualifierName": [], "DescriptorName": "Heart Injuries"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "p38 Mitogen-Activated Protein Kinases"}], "CoiStatement": "The authors declare that there are no conflict of interest in this study."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Buja L.M. Myocardial ischemia and reperfusion injury. Cardiovasc. Pathol. 2005;14:170\u2013175. doi: 10.1016/j.carpath.2005.03.006.", "ArticleIdList": ["10.1016/j.carpath.2005.03.006", "16009313"]}, {"Citation": "Ong S.B., Hern\u00e1ndez-Res\u00e9ndiz S., Crespo-Avilan G.E., Mukhametshina R.T., Kwek X.Y., Cabrera-Fuentes H.A., Hausenloy D.J. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol. Ther. 2018;186:73\u201387. doi: 10.1016/j.pharmthera.2018.01.001.", "ArticleIdList": ["10.1016/j.pharmthera.2018.01.001", "PMC5981007", "29330085"]}, {"Citation": "Lu Y., Yang M., Peng M., Xie L., Shen A., Lin S., Huang B., Chu J., Peng J. Kuanxiong aerosol inhibits apoptosis and attenuates isoproterenol-induced myocardial injury through the mitogen-activated protein kinase pathway. J. Ethnopharmacol. 2021;269:113757. doi: 10.1016/j.jep.2020.113757.", "ArticleIdList": ["10.1016/j.jep.2020.113757", "33359915"]}, {"Citation": "Choi D., Hwang K.C., Lee K.Y., Kim Y.H. Ischemic heart diseases: Current treatments and future. J. Control Release. 2009;140:194\u2013202. doi: 10.1016/j.jconrel.2009.06.016.", "ArticleIdList": ["10.1016/j.jconrel.2009.06.016", "19563848"]}, {"Citation": "Jia Q., Wang L., Zhang X., Ding Y., Li H., Yang Y., Zhang A., Li Y., Lv S., Zhang J. Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota. Pharmacol. Res. 2020;151:104552. doi: 10.1016/j.phrs.2019.104552.", "ArticleIdList": ["10.1016/j.phrs.2019.104552", "31747557"]}, {"Citation": "Liao S.G., Li Y.T., Zhang L.J., Wang Z., Chen T.X., Huang Y., Li J., Wang A.M., Li Y.J., Lan Y.Y., et al. UPLC-PDA-ESI-MS/MS analysis of compounds extracted by cardiac h9c2 cell from Polygonum orientale. Phytochem. Anal. 2013;24:25\u201335. doi: 10.1002/pca.2374.", "ArticleIdList": ["10.1002/pca.2374", "22714863"]}, {"Citation": "Huang Y., Zhang P., He F., Zheng L., Wang Y.L., Wu J.Z. Simultaneous determination of four bioactive flavonoids from Polygonum orientale L. in dog plasma by UPLC-ESI-MS/MS and application of the technique to pharmacokinetic studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2014;957:96\u2013104. doi: 10.1016/j.jchromb.2014.02.055.", "ArticleIdList": ["10.1016/j.jchromb.2014.02.055", "24662144"]}, {"Citation": "Lu Y., Li N., Lyu T., Wang Y.L., Pan J., Sun J., Li Y.J., Liu C.H. Pharmacokinetic study of Polygonum orientale extract in H9c2 cells by UPLC-MS/MS. China J. Chin. Mater. Med. 2021;46:4833\u20134840.", "ArticleIdList": ["34581095"]}, {"Citation": "Lu Y., Li N., Zhu X., Pan J., Wang Y., Lan Y., Li Y., Wang A., Sun J., Liu C. Comparative analysis of excretion of six major compounds of Polygonum orientale L. extract in urine, feces and bile under physiological and myocardial ischemia conditions in rats using UPLC-MS/MS. Biomed. Chromatogr. 2021;35:24. doi: 10.1002/bmc.5174.", "ArticleIdList": ["10.1002/bmc.5174", "33998022"]}, {"Citation": "Hepworth E.M.W., Hinton S.D. Pseudophosphatases as Regulators of MAPK Signaling. Int. J. Mol. Sci. 2021;22:12595. doi: 10.3390/ijms222212595.", "ArticleIdList": ["10.3390/ijms222212595", "PMC8622459", "34830476"]}, {"Citation": "Muslin A.J. MAPK signalling in cardiovascular health and disease: Molecular mechanisms and therapeutic targets. Clin. Sci. (Lond.) 2008;115:203\u2013218. doi: 10.1042/CS20070430.", "ArticleIdList": ["10.1042/CS20070430", "PMC2707780", "18752467"]}, {"Citation": "Li D.Y., Tao L., Liu H., Christopher T.A., Lopez B.L., Ma X.L. Role of ERK1/2 in the anti-apoptotic and cardioprotective effects of nitric oxide after myocardial ischemia and reperfusion. Apoptosis: Int. J. Program. Cell Death. 2006;11:923\u2013930. doi: 10.1007/s10495-006-6305-6.", "ArticleIdList": ["10.1007/s10495-006-6305-6", "16547595"]}, {"Citation": "Shimada K., Nakamura M., Ishida E., Kishi M., Konishi N. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis. 2003;24:1067\u20131075. doi: 10.1093/carcin/bgg058.", "ArticleIdList": ["10.1093/carcin/bgg058", "12807754"]}, {"Citation": "Javadov S., Jang S., Agostini B. Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: Therapeutic perspectives. Pharmacol. Ther. 2014;144:202\u2013225. doi: 10.1016/j.pharmthera.2014.05.013.", "ArticleIdList": ["10.1016/j.pharmthera.2014.05.013", "PMC4185221", "24924700"]}, {"Citation": "Romero-Becerra R., Santamans A.M., Folgueira C., Sabio G. p38 MAPK Pathway in the Heart: New Insights in Health and Disease. Int. J. Mol. Sci. 2020;21:7412. doi: 10.3390/ijms21197412.", "ArticleIdList": ["10.3390/ijms21197412", "PMC7582802", "33049962"]}, {"Citation": "Rose B.A., Force T., Wang Y. Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale. Physiol. Rev. 2010;90:1507\u20131546. doi: 10.1152/physrev.00054.2009.", "ArticleIdList": ["10.1152/physrev.00054.2009", "PMC3808831", "20959622"]}, {"Citation": "Zhu H., Jin Q., Li Y., Ma Q., Wang J., Li D., Zhou H., Chen Y. Melatonin protected cardiac microvascular endothelial cells against oxidative stress injury via suppression of IP3R-[Ca(2+)]c/VDAC-[Ca(2+)]m axis by activation of MAPK/ERK signaling pathway. Cell Stress Chaperones. 2018;23:101\u2013113. doi: 10.1007/s12192-017-0827-4.", "ArticleIdList": ["10.1007/s12192-017-0827-4", "PMC5741585", "28669047"]}, {"Citation": "Suchal K., Malik S., Gamad N., Malhotra R.K., Goyal S.N., Chaudhary U., Bhatia J., Ojha S., Arya D.S. Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury. Oxid. Med. Cell. Longev. 2016;2016:7580731. doi: 10.1155/2016/7580731.", "ArticleIdList": ["10.1155/2016/7580731", "PMC4819110", "27087891"]}, {"Citation": "Li C., Wan W., Ye T., Sun Y., Chen X., Liu X., Shi S., Zhang Y., Qu C., Yang B., et al. Pinocembrin alleviates lipopolysaccharide-induced myocardial injury and cardiac dysfunction in rats by inhibiting p38/JNK MAPK pathway. Life Sci. 2021;277:119418. doi: 10.1016/j.lfs.2021.119418.", "ArticleIdList": ["10.1016/j.lfs.2021.119418", "33781824"]}, {"Citation": "Xu Z., Sun J., Tong Q., Lin Q., Qian L., Park Y., Zheng Y. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy. Int. J. Mol. Sci. 2016;17:2001. doi: 10.3390/ijms17122001.", "ArticleIdList": ["10.3390/ijms17122001", "PMC5187801", "27941647"]}, {"Citation": "Chen H.T., Yang C.X., Li H., Zhang C.J., Wen X.J., Zhou J., Fan Y.L., Huang T., Zeng Y.M. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts. Acta Pharmacol. Sin. 2008;29:931\u2013941. doi: 10.1111/j.1745-7254.2008.00824.x.", "ArticleIdList": ["10.1111/j.1745-7254.2008.00824.x", "18664326"]}, {"Citation": "Lambert J.P., Nicholson C.K., Amin H., Amin S., Calvert J.W. Hydrogen sulfide provides cardioprotection against myocardial/ischemia reperfusion injury in the diabetic state through the activation of the RISK pathway. Med. Gas Res. 2014;4:20. doi: 10.1186/s13618-014-0020-0.", "ArticleIdList": ["10.1186/s13618-014-0020-0", "PMC4269946", "25525500"]}, {"Citation": "Yu D., Li M., Tian Y., Liu J., Shang J. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury. Life Sci. 2015;122:15\u201325. doi: 10.1016/j.lfs.2014.11.014.", "ArticleIdList": ["10.1016/j.lfs.2014.11.014", "25476833"]}, {"Citation": "Belch J.J., Bridges A.B., Scott N., Chopra M. Oxygen free radicals and congestive heart failure. Br. Heart J. 1991;65:245\u2013248. doi: 10.1136/hrt.65.5.245.", "ArticleIdList": ["10.1136/hrt.65.5.245", "PMC1024624", "2039668"]}, {"Citation": "M\u00f6llmann H., Nef H.M., Kostin S., Dragu A., Maack C., Weber M., Troidl C., Rolf A., Els\u00e4sser A., B\u00f6hm M., et al. Ischemia triggers BNP expression in the human myocardium independent from mechanical stress. Int. J. Cardiol. 2010;143:289\u2013297. doi: 10.1016/j.ijcard.2009.03.012.", "ArticleIdList": ["10.1016/j.ijcard.2009.03.012", "19329198"]}, {"Citation": "Palazzuoli A., Gallotta M., Quatrini I., Nuti R. Natriuretic peptides (BNP and NT-proBNP): Measurement and relevance in heart failure. Vasc. Health Risk Manag. 2010;6:411\u2013418. doi: 10.2147/VHRM.S5789.", "ArticleIdList": ["10.2147/VHRM.S5789", "PMC2882893", "20539843"]}, {"Citation": "Tian J., Zhao Y., Liu Y., Liu Y., Chen K., Lyu S. Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective. Oxid. Med. Cell. Longev. 2017;2017:8214541. doi: 10.1155/2017/8214541.", "ArticleIdList": ["10.1155/2017/8214541", "PMC5674516", "29204251"]}, {"Citation": "Li H., Sun K., Zhao R., Hu J., Hao Z., Wang F., Lu Y., Liu F., Zhang Y. Inflammatory biomarkers of coronary heart disease. Front. Biosci. (Schol. Ed) 2018;10:185\u2013196.", "ArticleIdList": ["28930526"]}, {"Citation": "Kleinbongard P., Schulz R., Heusch G. TNF\u03b1 in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail. Rev. 2011;16:49\u201369. doi: 10.1007/s10741-010-9180-8.", "ArticleIdList": ["10.1007/s10741-010-9180-8", "20571888"]}, {"Citation": "Wang M., Li J., Cai J., Cheng L., Wang X., Xu P., Li G., Liang X. Overexpression of MicroRNA-16 Alleviates Atherosclerosis by Inhibition of Inflammatory Pathways. Biomed Res. Int. 2020;2020:8504238. doi: 10.1155/2020/8504238.", "ArticleIdList": ["10.1155/2020/8504238", "PMC7391121", "32775445"]}, {"Citation": "Razavi H.M., Hamilton J.A., Feng Q. Modulation of apoptosis by nitric oxide: Implications in myocardial ischemia and heart failure. Pharmacol. Ther. 2005;106:147\u2013162. doi: 10.1016/j.pharmthera.2004.11.006.", "ArticleIdList": ["10.1016/j.pharmthera.2004.11.006", "15866317"]}, {"Citation": "Cotton J.M., Kearney M.T., MacCarthy P.A., Grocott-Mason R.M., McClean D.R., Heymes C., Richardson P.J., Shah A.M. Effects of nitric oxide synthase inhibition on Basal function and the force-frequency relationship in the normal and failing human heart in vivo. Circulation. 2001;104:2318\u20132323. doi: 10.1161/hc4401.098515.", "ArticleIdList": ["10.1161/hc4401.098515", "11696472"]}, {"Citation": "Shah A.M., Prendergast B.D., Grocott-Mason R., Lewis M.J., Paulus W.J. The influence of endothelium-derived nitric oxide on myocardial contractile function. Int. J. Cardiol. 1995;50:225\u2013231. doi: 10.1016/0167-5273(95)02381-6.", "ArticleIdList": ["10.1016/0167-5273(95)02381-6", "8537145"]}, {"Citation": "Hare J.M., Colucci W.S. Role of nitric oxide in the regulation of myocardial function. Prog. Cardiovasc. Dis. 1995;38:155\u2013166. doi: 10.1016/S0033-0620(05)80004-0.", "ArticleIdList": ["10.1016/S0033-0620(05)80004-0", "7568904"]}, {"Citation": "Riquelme J.A., Westermeier F., Hall A.R., Vicencio J.M., Pedrozo Z., Ibacache M., Fuenzalida B., Sobrevia L., Davidson S.M., Yellon D.M., et al. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism. Pharmacol. Res. 2016;103:318\u2013327. doi: 10.1016/j.phrs.2015.11.004.", "ArticleIdList": ["10.1016/j.phrs.2015.11.004", "26607864"]}, {"Citation": "Kingery J.R., Hamid T., Lewis R.K., Ismahil M.A., Bansal S.S., Rokosh G., Townes T.M., Ildstad S.T., Jones S.P., Prabhu S.D. Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure. Basic Res. Cardiol. 2017;112:19. doi: 10.1007/s00395-017-0609-2.", "ArticleIdList": ["10.1007/s00395-017-0609-2", "PMC5555149", "28238121"]}, {"Citation": "Speranza L., Franceschelli S., Riccioni G., Di Nicola M., Ruggeri B., Gallina S., Felaco M., Grilli A. BNP and iNOS in decompensated chronic heart failure: A linear correlation. Front. Biosci. (Elite Ed.) 2012;4:1255\u20131262. doi: 10.2741/e456.", "ArticleIdList": ["10.2741/e456", "22201951"]}, {"Citation": "Feng L., Ren J., Li Y., Yang G., Kang L., Zhang S., Ma C., Li J., Liu J., Yang L., et al. Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B/AMPK/eNOS/NO signalling pathway. Free Radic. Res. 2019;53:82\u201393. doi: 10.1080/10715762.2018.1554901.", "ArticleIdList": ["10.1080/10715762.2018.1554901", "30526144"]}, {"Citation": "Zhu Z., Ling X., Zhou H., Zhang C., Yan W. Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress. Drug Des. Devel. Ther. 2020;14:4231\u20134243. doi: 10.2147/DDDT.S265970.", "ArticleIdList": ["10.2147/DDDT.S265970", "PMC7568428", "33116411"]}, {"Citation": "Pahlavani H.A. Exercise-induced signaling pathways to counteracting cardiac apoptotic processes. Front. Cell Dev. Biol. 2022;10:950927. doi: 10.3389/fcell.2022.950927.", "ArticleIdList": ["10.3389/fcell.2022.950927", "PMC9403089", "36036015"]}, {"Citation": "Yang B., Ye D., Wang Y. Caspase-3 as a therapeutic target for heart failure. Expert Opin. Ther. Targets. 2013;17:255\u2013263. doi: 10.1517/14728222.2013.745513.", "ArticleIdList": ["10.1517/14728222.2013.745513", "23294432"]}, {"Citation": "Yueting L., Ting L., Qiong W., Dingyan L., Mingjin W., Yonglin W., Yongjun L., Meng Z., Chunhua L. Study on Improvement Effect of polygonum orientale Flower Extract on hypoxia-reoxygenation injury of H9c2 cardiomyocytes. China Pharmacy. 2021;32:1304\u20131312."}, {"Citation": "Ting L., Qiong W., Xiang-xiang L., Ding-Yan L., Wen-Xuan H., Yue-Ting L., Yong-Jun L. Protective Effect of Flowers of Polygonum orientale Flower Ethanol Extract on H2O2-induced Oxidative Stress Injury in H9c2 Cells. Nat. Prod. Res. 2018;30:299\u2013303."}, {"Citation": "Chun-hua L., Ming-jin W., Shu-ting Y., Na L., Yuan L., Jie P., Yong-jun L., Yong-lin W., Jia S. Intestinal absorption characteristics of Polygonum orientale extract in normal and isoproterenol-induced myocardial ischemia model rats via everted intestinal sac models. Chin. Med. J. 2021;46:196\u2013205.", "ArticleIdList": ["33645071"]}, {"Citation": "Yu X., Chen X., Amrute-Nayak M., Allgeyer E., Zhao A., Chenoweth H., Clement M., Harrison J., Doreth C., Sirinakis G., et al. MARK4 controls ischaemic heart failure through microtubule detyrosination. Nature. 2021;594:560\u2013565. doi: 10.1038/s41586-021-03573-5.", "ArticleIdList": ["10.1038/s41586-021-03573-5", "PMC7612144", "34040253"]}, {"Citation": "Rui-qing Q. Clinical Analysis of Compound Danshen Dripping Pills for Treating Community Coronary Heart Disease. Chin. Community Dr. 2022;38:99\u2013101."}, {"Citation": "Jia S., Jie P., Lan Q., Shuting Y., Chunhua L., Xinglian X., Yonglin W., Yuan L. Effect and mechanism of Polygonum orientale L.extract on isoproterenol-induced acute myocardial ischemia in rats. J. Guizhou Med. Univ. 2021;46:275\u2013280."}, {"Citation": "Qi J.Y., Yu J., Huang D.H., Guo L.H., Wang L., Huang X., Huang H.D., Zhou M., Zhang M.Z., Wu J. Salvianolate reduces murine myocardial ischemia and reperfusion injury via ERK1/2 signaling pathways in vivo. Chin. J. Integr. Med. 2017;23:40\u201347. doi: 10.1007/s11655-016-2621-z.", "ArticleIdList": ["10.1007/s11655-016-2621-z", "27787719"]}, {"Citation": "Rezkalla S., Kloner R.A., Khatib G., Smith F.E., Khatib R. Effect of metoprolol in acute coxsackievirus B3 murine myocarditis. J. Am. Coll. Cardiol. 1988;12:412\u2013414. doi: 10.1016/0735-1097(88)90414-7.", "ArticleIdList": ["10.1016/0735-1097(88)90414-7", "2839568"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "20"}, {"Year": "2023", "Month": "4", "Day": "6"}, {"Year": "2023", "Month": "4", "Day": "20"}, {"Year": "2023", "Month": "5", "Day": "15", "Hour": "11", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "13", "Hour": "15", "Minute": "12"}, {"Year": "2023", "Month": "5", "Day": "13", "Hour": "1", "Minute": "25"}, {"Year": "2023", "Month": "4", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["37175097", "PMC10180121", "10.3390/molecules28093687", "molecules28093687"]}}], "PubmedBookArticle": []}